TrialBioMed research international2014

CD49b, a major marker of regulatory T-cells type 1, predicts the response to antiviral therapy of recurrent hepatitis C after liver transplantation.

Stenard Fabien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.